OMAHA, Neb. (KMTV) — The first clinical trial in the U.S. of a possible coronavirus treatment is underway in Nebraska and is eventually expected to include 400 patients at 50 locations around the world.
Half the patients will receive the antiviral medicine remdesivir while the other half will receive a placebo. Several other studies are already underway internationally.
Dr. Andre Kalil, who will oversee the study at the University of Nebraska Medical Center, said Tuesday the clinical trial was developed quickly in response to the virus outbreak that is centered in China.
Dr. Andre Kalil says a medication has been developed and is being tested on patients. They’re starting in Nebraska and have hopes to test this out internationally. pic.twitter.com/DdbO0hMLti— Ruta Ulcinaite KMTV (@RutaUlcinaite) February 25, 2020
The patients treated in this trial initially will be the ones already severally ill with the disease.— Ruta Ulcinaite KMTV (@RutaUlcinaite) February 25, 2020
The medication will be distributed through an IV line. There will be placebo injections as well to make sure to remove bias from this trial.— Ruta Ulcinaite KMTV (@RutaUlcinaite) February 25, 2020